HLA-A*0201 | B2M & HIV Gag

Product Inquiry

HLA-A*0201 | B2M & HIV Gag Background

HIV (human immunodeficiency virus) is a virus that attacks the body’s immune system. If HIV is not treated, it can lead to AIDS (acquired immunodeficiency syndrome). It can be transmitted via the exchange of a variety of body fluids from infected people, such as blood, breast milk, semen and vaginal secretions, And from a mother to her child during pregnancy and delivery. This disease can be managed by treatment regimens composed of a combination of antiretroviral (ARV) drugs. The Human HLA-A*0201 HIV (SLYNTVATL) complex protein is a complex of HLA-A*0201 of the MHC Class I, B2M, and SLYNTVATL peptide of the HIV.

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
KLS-2031KLS-2031Phase 2 ClinicalKolon Life Science. IncRadiculopathy
Details
NGM-386NGM-386Phase 1 ClinicalNgm Biopharmaceuticals IncObesity
Details
NGM-395NGM-395Phase 1 ClinicalNgm Biopharmaceuticals IncMetabolic Dysfunction-Associated Steatotic Liver Disease; Obesity
Details
  • Product Inquiry
  • Clinical Drug Information
Contact Us

전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521

주소 서울특별시 송파구 법원로11길 11, 제3층 제비-314,315호